Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/26/2012US8207189 Compound having affinity for amyloid
06/26/2012US8207188 Treatment of diseases modulated by a H4 receptor agonist
06/26/2012US8207187 Use of pyrroloquinoline compounds to kill clinically latent microorganisms
06/26/2012US8207186 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase MET
06/26/2012US8207185 CaMKKβ as a target for treating obesity
06/26/2012US8207184 Condensation compound between fluorinated cyclopentane ring and aromatic ring, and process for producing the same
06/26/2012US8207183 Inhibitors of IAP
06/26/2012US8207182 Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators
06/26/2012US8207181 Substituted dihydro, trihydro and tetrahydro cycloalkyloxazolopyrimidinones, preparation and use thereof
06/26/2012US8207180 Tricyclic indoles and (4,5-dihydro) indoles
06/26/2012US8207179 Substituted indolines as tyrosine kinase inhibitors
06/26/2012US8207178 Fused pyrimidines as reverse transcriptase inhibitors
06/26/2012US8207177 Inhibitors of E1 activating enzymes
06/26/2012US8207176 Compounds
06/26/2012US8207175 Inhibitor compounds
06/26/2012US8207174 Beta-3 adrenergic receptor agonists; urinary tract infections, incontinence, gastrointestinal disorders, dysmenorrhea, obesity; tocolytic, anxiolytic, antidiabetic agents; antidepressants; 4-(2-hydroxy-3-(1-(5-phenylthieno[2,3-d]pyrimidin-4-yl)piperidin-4-ylamino)propoxy)phenol
06/26/2012US8207173 Benzimidazoles and analogs thereof as antivirals
06/26/2012US8207171 Cosmetic use of 1-Aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamides and related compounds
06/26/2012US8207170 Heterocyclic substituted piperazines with CXCR3 antagonist activity
06/26/2012US8207169 Substituted [1,2,4]triazolo[4′,3′:1,6]pyrido[2,3-b]pyrazines of the formula D
06/26/2012US8207168 Pyridazinone derivatives
06/26/2012US8207167 Aryl-phenyl-sulfonamide-phenylene compounds and their use
06/26/2012US8207166 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
06/26/2012US8207165 3,4-dihydro-2H-pyrazino[1,2-A]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2012US8207164 Oxazine derivatives and their use in the treatment of neurological disorders
06/26/2012US8207163 Compositions, synthesis, and methods of using piperazine based antipsychotic agents
06/26/2012US8207162 Chiral fused [1,2]imidazo[4,5-c] ring compounds
06/26/2012US8207161 Tetrahydro-imidazo[1,5-α]pyrazine derivatives, preparation process and medicinal use thereof
06/26/2012US8207160 Tetrahydrobenzazepines and their use in he modulation of the dopamine D3 receptor
06/26/2012US8207159 for the treatment of disorders of the central nervous system such as cerebral, central nervous or psychiatric symptoms, defunctionalization manifestations or disorders which occur as a result of unintentional or intentional intake of psychotropic
06/26/2012US8207158 5HT2c receptor modulators
06/26/2012US8207156 Substituted pyrazoline compounds, their preparation and use as medicaments
06/26/2012US8207155 Sulfonyl-azetidin-3-yl-methylamine amide analogs as GlyTl inhibitors, methods for making same, and use of same in treating psychiatric disorders
06/26/2012US8207154 Palladium 31-oxo-15- methoxycarbonylmethyl- Rhodobacteriochlorin-131-(2-N3- trimethylammoniumethyl)amide acetate (salt); bacteriochlorophylls free of carbamate group; as photosensitizer for thermodynamic therapy and diagnosis; cancer, age related macular degeneration; killing viruses and bacteria
06/26/2012US8207153 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
06/26/2012US8207152 Methods for treating or preventing cancer by preventing, inhibiting, or arresting cell cycling
06/26/2012US8207151 Non-hormonal steroid modulators of NF-κB for treatment of disease
06/26/2012US8207150 17β-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative
06/26/2012US8207149 Method for treating secondary hyperparathyroidism in CKD
06/26/2012US8207148 Compositions containing zinc salts for coating medical articles
06/26/2012US8207147 Heterocyclic derivatives as GPCR receptor agonists
06/26/2012US8207146 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical
06/26/2012US8207145 Using pharmaceutical preparation of mucopolysaccharides having an anticoagulant activity of <100 BP units/mg for prophylactic priming or curative treatment of the cervix and the myometrium; sulfates of heparin chondroitin and dermatan and their depolymerized products
06/26/2012US8207144 Improves the stability over time of a corresponding tetrasodium salt useful as a preventive or therapeutic for septicemia, endotoxemia or improving prognosis following coronary artery bypass surgery
06/26/2012US8207143 Methods of treating cancer and other conditions or disease states using LFMAU and LDT
06/26/2012US8207142 Inhibitor of DNA methylation
06/26/2012US8207140 Oligomeric compounds for the modulation of HIF-1α expression
06/26/2012US8207136 Nucleoside compounds and methods of use thereof
06/26/2012US8207134 Fused ring spiroketal derivative and use thereof as anti-diabetic drug
06/26/2012US8207109 Food supplement with a slimming effect
06/26/2012US8207089 Concentrated compositions that provide disease and pest control to plants
06/26/2012US8206931 Methods of identifying modulators of cellular glycosylation using GTRAP3-18
06/26/2012US8206759 Method of reducing blood cholesterol and triglyceride levels using combinations of vasoprotective agent
06/26/2012US8206740 Once daily formulations of tetracyclines
06/26/2012US8206737 Hypotensive lipid-containing biodegradable intraocular implants and related methods
06/26/2012US8206736 Biocompatible intraocular implants include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide component into an eye for an extended period of time. The prostamide component may be associated with a biodegradable polymer matrix, such as a matrix
06/26/2012US8206727 Oral suspension of prednisolone acetate
06/26/2012US8206718 Expression and export of angiogenesis inhibitors as immunofusins
06/26/2012US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa
06/26/2012US8206711 Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies
06/26/2012US8206707 Combination therapy for the treatment of ocular neovascular disorders
06/26/2012US8206699 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
06/26/2012US8206696 viscosity is sufficiently low to allow for easy application and dispensation, but sufficiently high to cause the solution to remain in the area of the wound and not flow away from the prep site; forms a water-resistant film that is fast drying
06/26/2012US8206688 Foam-forming composition
06/26/2012US8206636 Stent fabrication via tubular casting processes
06/26/2012US8206635 Stent fabrication via tubular casting processes
06/26/2012CA2691914C Pharmaceutical compositions and methods of treating dry eye disorders
06/26/2012CA2690490C Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
06/26/2012CA2669753C Therapeutic treatment of androgen receptor driven conditions
06/26/2012CA2661607C Compositions and methods for treating or preventing glaucoma or progression thereof
06/26/2012CA2648518C Treatment of hematological malignancies with fts and a bcr-abl tyrosine kinase inhibitor
06/26/2012CA2635093C Derivatives of sulindac, use thereof and preparation thereof
06/26/2012CA2603810C Potentiator for radiation therapy comprising pyridine derivative as active ingredient
06/26/2012CA2602362C Benzoic acid ester compounds, compositions, uses and methods related thereto
06/26/2012CA2575232C 5-substituted-2-phenylamino-benzamide as mek inhibitor
06/26/2012CA2566609C Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
06/26/2012CA2556200C C10 cyclopentyl ester substituted taxanes
06/26/2012CA2555804C Polymorphic form of imatinib mesylate and a process for its preparation
06/26/2012CA2554493C Bicycloester derivative
06/26/2012CA2545704C Novel 17.beta.-hydroxysteroid dehydrogenase type i inhibitors
06/26/2012CA2545524C Process for preparing phytosterol dispersions for application in beverages
06/26/2012CA2536185C Drug delivery system by administrating fine particles to sub-tenon
06/26/2012CA2517020C Dihydropteridinones, method for the production and use thereof in the form of drugs
06/26/2012CA2511970C Urea derivatives useful in the treatment of heart failure
06/26/2012CA2504941C 3-substituted-6-aryl pyridines
06/26/2012CA2503211C Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent
06/26/2012CA2472581C Tricyclic-bis-enone derivatives and methods of use thereof
06/26/2012CA2468082C Assay for screening candidate drugs for the treatment of inflammatory diseases
06/26/2012CA2458126C Composition for stabilizing hyaluronic acid
06/26/2012CA2443857C Bisphosphonate conjugates and methods of making and using the same
06/26/2012CA2438582C Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/26/2012CA2426952C Small molecule compositions for binding to hsp90
06/26/2012CA2425602C Methods of high-throughput screening for internalizing antibodies
06/26/2012CA2395678C Antimicrobial compositions and methods of use
06/26/2012CA2382832C Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
06/26/2012CA2371689C Preparations for the application of anti-infective and/or anti-inflammatory agents to external or internal parts of the human or animal body in functional and cosmetic tissue remodelling and repair treatment
06/26/2012CA2328614C Matrices for drug delivery and methods for making and using the same
06/26/2012CA2319713C Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
06/26/2012CA2237316C Complex cationic lipids
06/23/2012CA2760714A1 A device for coating a medical implant and a method for using same
1 ... 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 ... 7860